David Martin
Directeur de la Recherche - Actions chez Bloom Burton & Co.
Profil
Dr. David Martin is a Managing Director & Head of Equity Research at Bloom Burton & Co. By seeking out and researching publicly traded healthcare and emerging biotechnology companies, he identifies opportunities that are differentiated and undervalued, thereby providing for Bloom Burton’s clients, investment ideas with the potential for substantial returns.
Before joining Bloom Burton, Dr. Martin most recently served as Vice President, Corporate Development and Investor Relations at a high growth medical device company.
Earlier in his career, he led the Healthcare Equity Research team at one of Canada’s largest independent investment dealers, and he has also worked in the clinical diagnostics industry.
Dr. Martin received a Ph.D.
Biochemistry from the University of Western Ontario for oncology research.
He also holds a MBA degree from the Richard Ivey School of Business.
Postes actifs de David Martin
| Sociétés | Poste | Début |
|---|---|---|
Bloom Burton & Co.
 Bloom Burton & Co. Investment Banks/BrokersFinance Bloom Burton & Co. is an independent, Canadian broker/dealer headquartered in Toronto, Ontario. It was founded by Brian Bloom and Jolyon Burton in 2008. The firm offers bespoke execution services for healthcare institutional investors. They are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness. | Directeur de la Recherche - Actions | 01/06/2014 |
Anciens postes connus de David Martin
| Sociétés | Poste | Fin |
|---|---|---|
| NOVADAQ TECHNOLOGIES INC. | Investor Relations Contact | - |
| Boehringer Mannheim Canada Ltd. | Corporate Officer/Principal | - |
DWM Securities, Inc.
 DWM Securities, Inc. Investment ManagersFinance Dundee Securities Corp. is a broker/dealer located in Toronto with additional offices in Montreal and Calgary. The firm is a subsidiary of Dundee Wealth Management, Inc. (TSE: DW). Dundee Securities is a full service investment dealer engaged in wealth management and financial advisory services, retail brokerage, institutional sales and trading, equity research and investment banking. The firm operates a sell-side institutional sales and trading floor. Dundee Securities is a member of the Investment Dealers Association of Canada and the CIPF. | Analyst-Equity | - |
Formation de David Martin
| University of Western Ontario | Doctorate Degree |
| University of Toronto | Graduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
DWM Securities, Inc.
DWM Securities, Inc. Investment ManagersFinance Dundee Securities Corp. is a broker/dealer located in Toronto with additional offices in Montreal and Calgary. The firm is a subsidiary of Dundee Wealth Management, Inc. (TSE: DW). Dundee Securities is a full service investment dealer engaged in wealth management and financial advisory services, retail brokerage, institutional sales and trading, equity research and investment banking. The firm operates a sell-side institutional sales and trading floor. Dundee Securities is a member of the Investment Dealers Association of Canada and the CIPF. | Finance |
Novadaq Technologies, Inc.
 Novadaq Technologies, Inc. Medical SpecialtiesHealth Technology Novadaq Technologies, Inc. was engaged in the development, manufacture, and market of real-time fluorescence imaging products. The company was founded by Rick Mangat on April 14, 2000 and was headquartered in Mississauga, Canada. | Health Technology |
Bloom Burton & Co.
Bloom Burton & Co. Investment Banks/BrokersFinance Bloom Burton & Co. is an independent, Canadian broker/dealer headquartered in Toronto, Ontario. It was founded by Brian Bloom and Jolyon Burton in 2008. The firm offers bespoke execution services for healthcare institutional investors. They are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness. | Finance |
| Boehringer Mannheim Canada Ltd. |
